Literature DB >> 26510698

Restoration of Pulsatile Flow Reduces Sympathetic Nerve Activity Among Individuals With Continuous-Flow Left Ventricular Assist Devices.

William K Cornwell1, Takashi Tarumi1, Abigail Stickford1, Justin Lawley1, Monique Roberts1, Rosemary Parker1, Catherine Fitzsimmons1, Julius Kibe1, Colby Ayers1, David Markham1, Mark H Drazner1, Qi Fu1, Benjamin D Levine1.   

Abstract

BACKGROUND: Current-generation left ventricular assist devices provide circulatory support that is minimally or entirely nonpulsatile and are associated with marked increases in muscle sympathetic nerve activity (MSNA), likely through a baroreceptor-mediated pathway. We sought to determine whether the restoration of pulsatile flow through modulations in pump speed would reduce MSNA through the arterial baroreceptor reflex. METHODS AND
RESULTS: Ten men and 3 women (54 ± 14 years) with Heartmate II continuous-flow left ventricular assist devices underwent hemodynamic and sympathetic neural assessment. Beat-to-beat blood pressure, carotid ultrasonography at the level of the arterial baroreceptors, and MSNA via microneurography were continuously recorded to determine steady-state responses to step changes (200-400 revolutions per minute) in continuous-flow left ventricular assist device pump speed from a maximum of 10,480 ± 315 revolutions per minute to a minimum of 8500 ± 380 revolutions per minute. Reductions in pump speed led to increases in pulse pressure (high versus low speed: 17 ± 7 versus 26 ± 12 mm Hg; P<0.01), distension of the carotid artery, and carotid arterial wall tension (P<0.05 for all measures). In addition, MSNA was reduced (high versus low speed: 41 ± 15 versus 33 ± 16 bursts per minute; P<0.01) despite a reduction in mean arterial pressure and was inversely related to pulse pressure (P=0.037).
CONCLUSIONS: Among subjects with continuous-flow left ventricular assist devices, the restoration of pulsatile flow through modulations in pump speed leads to increased distortion of the arterial baroreceptors with a subsequent decline in MSNA. Additional study is needed to determine whether reduction of MSNA in this setting leads to improved outcomes.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; heart failure; pressoreceptors; sympathetic nervous system; ventricular assist device

Mesh:

Year:  2015        PMID: 26510698     DOI: 10.1161/CIRCULATIONAHA.115.017647

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  CrossTalk opposing view: Blood flow pulsatility in left ventricular assist device patients is not essential to maintain normal brain physiology.

Authors:  William K Cornwell; Takashi Tarumi; Justin Lawley; Amrut V Ambardekar
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

2.  Rebuttal from Eric J. Stöhr, Barry J. McDonnell, Paolo C. Colombo and Joshua Z. Willey.

Authors:  Eric J Stöhr; Barry J McDonnell; Paolo C Colombo; Joshua Z Willey
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

Review 3.  Renal dysfunction and chronic mechanical circulatory support: from patient selection to long-term management and prognosis.

Authors:  Meredith A Brisco; Jeffrey M Testani; Jennifer L Cook
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

4.  Continuous-flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry.

Authors:  Kevin J Clerkin; Donna M Mancini; Josef Stehlik; Wida S Cherikh; Lars H Lund
Journal:  Clin Transplant       Date:  2019-11-26       Impact factor: 2.863

5.  Bionic women and men - Part 4: Cardiovascular, cerebrovascular and exercise responses among patients supported with left ventricular assist devices.

Authors:  Cullen Buchanan; Manreet Kanwar; John R Cockcroft; Barry McDonnell; Eric J Stöhr; William K Cornwell
Journal:  Exp Physiol       Date:  2020-03-18       Impact factor: 2.969

Review 6.  Patient-centered care for left ventricular assist device therapy: current challenges and future directions.

Authors:  Khadijah Breathett; Larry A Allen; Amrut V Ambardekar
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

7.  Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction.

Authors:  Marat Fudim; Joseph G Rogers; Camille Frazier-Mills; Chetan B Patel
Journal:  ASAIO J       Date:  2018 May/Jun       Impact factor: 2.872

8.  Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury.

Authors:  Matthieu Gautier; Lois Mahe; Jan Elaine Soriano; Andreas Rowald; Jordan W Squair; Arnaud Bichat; Newton Cho; Mark A Anderson; Nicholas D James; Jerome Gandar; Anthony V Incognito; Giuseppe Schiavone; Zoe K Sarafis; Achilleas Laskaratos; Kay Bartholdi; Robin Demesmaeker; Salif Komi; Charlotte Moerman; Bita Vaseghi; Berkeley Scott; Ryan Rosentreter; Claudia Kathe; Jimmy Ravier; Laura McCracken; Xiaoyang Kang; Nicolas Vachicouras; Florian Fallegger; Ileana Jelescu; YunLong Cheng; Qin Li; Rik Buschman; Nicolas Buse; Tim Denison; Sean Dukelow; Rebecca Charbonneau; Ian Rigby; Steven K Boyd; Philip J Millar; Eduardo Martin Moraud; Marco Capogrosso; Fabien B Wagner; Quentin Barraud; Erwan Bezard; Stéphanie P Lacour; Jocelyne Bloch; Grégoire Courtine; Aaron A Phillips
Journal:  Nature       Date:  2021-01-27       Impact factor: 49.962

9.  Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices.

Authors:  Suneet N Purohit; William K Cornwell; Jay D Pal; JoAnn Lindenfeld; Amrut V Ambardekar
Journal:  Circ Heart Fail       Date:  2018-06       Impact factor: 8.790

Review 10.  Vasoplegia from Continuous Flow Left Ventricular Assist Devices.

Authors:  Shyama Sathianathan; Geetha Bhat; Robert Dowling
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.